iRhythm announced that it plans to use Epic’s Aura platform to streamline access to its Zio long-term monitoring and telemetry services. With this collaboration, iRhythm can make Zio more readily available to healthcare providers using Epic. That also applies to the more than 250 million patients in the U.S. who have a health record in […]
Patient Monitoring
FDA submission for 365-day CGM from Senseonics is ‘imminent’
Senseonics (NYSE:SENS) shares dipped after hours on fourth-quarter results that came in ahead of the consensus forecast. The company also reported an “imminent” submission of its latest, longest-lasting continuous glucose monitoring (CGM) technology. Shares of SENS fell 3.5% to 69¢ apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of […]
Masimo stock dips despite Street-beating Q4
Masimo shares fell slightly despite fourth-quarter results that came in ahead of the consensus forecast. Shares of MASI dipped 2.6% at $126.76 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell 0.3%. The Irvine, California–based patient monitoring technology developer posted profits of […]
These diabetes devices are set to launch in 2024
The diabetes space continues to innovate, and it doesn’t look like that’s stopping any time soon, with 2024 set to be another banner year. At the end of 2023, we compiled a list of the 10 biggest diabetes technology stories of the year. Some of those stories didn’t end in 2023, though, as a few […]
Know Labs unveils wearable, non-invasive CGM set for FDA submission
Know Labs (NYSE:KNW) today unveiled KnowU, its wearable, non-invasive continuous glucose monitor (CGM) system. Seattle-based Know Labs first announced its initial prototype last June. It says KnowU is the result of an accelerated development process over the past eight months. The system incorporates the sensor developed by the company that it plans to submit for […]
Owlet to raise $9M to support infant monitoring tech
Owlet (NYSE:OWLT) announced today that it entered into agreements for a private placement worth proceeds of approximately $9 million. Lehi, Utah-based Owlet’s placement relates to the sale of shares of its newly issued Series B convertible preferred stock and warrants to purchase Class A common stock. The conversion ratio for the stock and warrants reflects […]
GE HealthCare, Biofourmis collab on at-home patient monitoring
GE HealthCare announced today that it entered into a collaboration with Biofourmis to enable safe, effective, accessible care in the home. The two companies paired up to support the patient journey beyond the hospital setting. Their collaboration leverages combined expertise in innovative care-at-home solutions. They say hospital systems face increased costs of care due to […]
iRhythm stock dips on mixed Q4 as guidance ‘may disappoint’ investors
iRhythm Technologies shares took a hit today on third-quarter results that came in mixed compared to the consensus forecast. Shares of IRTC fell 5.5% at $108.75 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — remained even. The San Francisco-based heart monitoring technology […]
Insulet begins limited rollout of Omnipod 5 with Dexcom G7, grows sales by 38% in Q4
Insulet announced that it began a limited market release of the Omnipod 5 with the Dexcom G7. This marks the latest integration of Dexcom’s next-generation CGM into automated insulin delivery technology. Omnipod 5, Insulet’s newest patch pump offering, previously worked with the G6 in the U.S. It also recently integrated the system with Abbott’s FreeStyle […]
FDA: Don’t use smartwatches, smart rings to measure blood glucose
The FDA issued a warning to consumers, patients, caregivers and providers around using certain technology to measure blood glucose. In the warning, the agency outlined the risks related to using smartwatches or smart rings for this purpose. Such devices may claim to measure blood glucose levels without piercing the skin. These devices are different from […]
EnsoData wins FDA nod for AI sleep diagnosis tech using pulse oximeters
EnsoData announced today that it received FDA 510(k) clearance for technology that enables AI-powered sleep diagnosis using pulse oximetry devices. Powered by the company’s EnsoSleep PPG scoring, widely available, wearable, FDA-cleared pulse oximetry technology can be used for sleep diagnosis, according to EnsoData. The company says it enables a high-quality, accessible and cost-effective approach to […]